Peripheral Neuropathy Trial, Recruiting (NCT07210203)

Peripheral Neuropathy Trial, Recruiting NCT07210203 Sponsor: Foundation University Islamabad Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT07210203 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People of any gender may be considered
People who have been diagnosed with diabetic peripheral neuropathy (nerve damage caused by diabetes)
People between the ages of 50 and 75 years old
People who have had type 2 diabetes for at least 5 years
People who are currently experiencing nerve-related symptoms such as pain, numbness, tingling, or problems with balance
People whose pain is rated as mild to moderate on a standard pain scale (confirm with trial site)

Who may not be able to join:

People who have a neurological condition such as stroke, multiple sclerosis, or Parkinson's disease
People who have a chronic pain condition not related to diabetic peripheral neuropathy, such as fibromyalgia or osteoarthritis
People who have active ulcers or infections on their lower limbs or feet
People whose diabetes is currently not well controlled
People who are unable to perform basic balance tests, such as standing without support for a short period of time

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +92 3458353129

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07210203

Sponsor: Foundation University Islamabad

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

Trial contact: +92 3458353129

More information: https://clinicaltrials.gov/study/NCT07210203

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People of any gender may be considered
People who have been diagnosed with diabetic peripheral neuropathy (nerve damage caused by diabetes)
People between the ages of 50 and 75 years old
People who have had type 2 diabetes for at least 5 years
People who are currently experiencing nerve-related symptoms such as pain, numbness, tingling, or problems with balance
People whose pain is rated as mild to moderate on a standard pain scale (confirm with trial site)

Who may not be able to join:

People who have a neurological condition such as stroke, multiple sclerosis, or Parkinson's disease
People who have a chronic pain condition not related to diabetic peripheral neuropathy, such as fibromyalgia or osteoarthritis
People who have active ulcers or infections on their lower limbs or feet
People whose diabetes is currently not well controlled
People who are unable to perform basic balance tests, such as standing without support for a short period of time

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Foundation University Islamabad

Registry

ClinicalTrials.gov

Start date

13 September 2024

Est. completion

10 December 2025

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Pain in Diabetic Neuropathy; Balance; Quality of life in Diabetic Neuropathy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov